{"brief_title": "Multicenter Trial For Patients With Acute Crohn's Disease", "brief_summary": "The purpose of this study is to see if etiprednol dicloacetate is safe and effective for the treatment of acute Crohn's disease.", "condition": "Crohn's Disease", "intervention_type": "Drug", "intervention_name": "etiprednol dicloacetate", "criteria": "- Must have active confirmed Crohn's disease with CDAI > 220 and < 400. - Otherwise healthy.", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "id": "NCT00035503.xml"}